Acute Ischemic Stroke With Central Retinal Artery Occlusion As a Rare Presentation of COVID-19 Disease
Overview
Affiliations
In this report, we present a case where the patient developed a border-zone ischemic stroke with central retinal artery occlusion (RAO) following coronavirus disease 2019 (COVID-19) disease. The COVID-19 disease has been described to induce inflammatory changes that predispose to thrombotic disease in both venous and arterial circulation. Angiotensin-converting enzyme 2 (ACE2) receptor expression in the blood vessel with which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds is the cornerstone of inflammation although the pathogenesis of central RAO is multifactorial. The effects of COVID-19 inflammatory and pro-coagulant state on cerebral and retinal vascular systems are still inadequately understood. Combined presentation of central RAO with ischemic stroke has not been documented in the literature yet. As of now, no guidelines exist regarding treatment modalities to be employed in such instances. Hence, further research is warranted regarding the treatment of this condition with respect to the association with COVID-19.
The spectrum of COVID-19-associated chorioretinal vasculopathy.
Carletti P, Shah A, Bair C, Curran C, Mai A, Patel R Am J Ophthalmol Case Rep. 2023; 31:101857.
PMID: 37255549 PMC: 10193817. DOI: 10.1016/j.ajoc.2023.101857.
Different Cases, Different Manifestations of Post-COVID-19 Retinal Artery Occlusion: A Case Series.
Yalcinbayir O, Ucan Gunduz G, Coskun F, Hakyemez B, Doganay S Turk J Ophthalmol. 2023; 53(2):124-129.
PMID: 37089035 PMC: 10127544. DOI: 10.4274/tjo.galenos.2022.36930.
Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review.
Yeo S, Kim H, Lee J, Yi J, Chung Y Graefes Arch Clin Exp Ophthalmol. 2023; 261(7):1793-1808.
PMID: 36598554 PMC: 9811047. DOI: 10.1007/s00417-022-05953-7.
Kang M, Kim S, Kwon H Front Pharmacol. 2022; 13:845615.
PMID: 35401231 PMC: 8988066. DOI: 10.3389/fphar.2022.845615.